ABIOMED, Inc. (ABMD) Buy or Sell Stock Guide

Last updated: Jul 12, '19

Are you looking for the analysis of ABIOMED, Inc. (ABMD) stock? Are you wondering what the bulls and the bears say about it?

If so, you came to the right place. In this stock guide, we will share with you 5 reasons to buy and 3 reasons to sell ABMD stock. You’ll get a perspective on what the bulls and the bears say about it.

The analysis below may be also helpful to you if you have any of the following questions about ABMD stock:

  • Is ABMD a buy or a sell?
  • Should I sell or hold ABMD stock today?
  • Is ABMD a good buy / investment?
  • What are ABMD analyst opinions, recommendations and ratings?

Let’s start with the bull case. Here are the reasons to buy ABMD stock:

1. ABMD quarterly revenue growth was 15.94%, higher than the industry and sector average revenue growth (5.28% and 3.11%, respectively). See ABMD revenue growth chart.

2. ABMD profitability is improving. The YoY profit margin change was 7.19percentage points. See ABMD profitability chart.

3. ABMD PEG ratio (P/E adjusted for growth) is 2.01, and it’s low compared to its industry peers’ PEG ratios. See ABMD PEG chart.

4. ABMD average analyst rating is Strong Buy. See ABMD analyst rating chart.

5. ABMD average analyst price target ($336.88) is above its current price ($266.09). See ABMD price target chart.

Now that you understand the bull case, let’s look at the reasons to sell ABMD stock (i.e., the bear case):

1. ABMD Price/Sales ratio is 15.34, and it’s high compared to its industry peers’ P/S ratios. See ABMD forward Price/Sales ratio chart.

2. ABMD short share of float is 5.73%. The stock is much more frequently shorted than the average industry, sector or S&P 500 stock. See ABMD short share of float chart.

3. ABMD short interest (days to cover the shorts) ratio is 3.93. The stock garners more short interest than the average industry, sector or S&P 500 stock. See ABMD short interest ratio chart.

Now let's look at the key statistics for ABMD:

Metrics ABMD
Price $262.98
Average Price Target / Upside $336.88 / 28.10%
Average Analyst Rating Strong Buy
Industry Medical Devices
Sector Healthcare
Number of Employees 208
Market Cap $11.49B
Forward P/E Ratio 55.8659
Price/Book Ratio 15.2201
PEG N/A
Revenue (TTM) $769.43M
YoY Quarterly Revenue Growth 15.942028985507244%
Profit Margin 33.66388105480681%

What are your thoughts on ABMD?

If you liked this analysis, check out Buy or Sell Stock Guides for other stocks.

Comments (0)expand_more